Cardiometabolic disease prevention and treatment guidelines
This webpage covers all NICE’s guidelines on cardiometabolic disease prevention and treatment The table presents the guidelines alphabetically within their topic area. Updates planned or in progress and areas we’re actively monitoring are listed for each guideline, and there are links to the individual update pages for more information.
Guidelines
Cardiovascular disease
Diabetes
Physical activity
Guideline |
Updates planned and in progress |
Key topic areas we’re proposing to actively monitor |
- |
To be confirmed |
|
- |
To be confirmed |
|
- |
To be confirmed |
|
- |
To be confirmed |
|
- |
To be confirmed |
|
- |
To be confirmed |
Weight management
Guideline |
Updates planned and in progress |
Key topic areas we’re proposing to actively monitor |
Overweight and obesity management | - |
To be confirmed |
Methods
Areas for active monitoring are identified by our maintaining and updating our guideline portfolio process including validation with stakeholders.
Active monitoring is ongoing surveillance in key topic areas. It involves one or more of:
- monitoring studies in progress by systematically searching for ongoing studies and assessing the results when published
- monitoring newly published studies by continuous searching of newly published evidence
- system monitoring by systematically collating intelligence from the health and care system and working with partners to identify areas of change.
Guideline recommendations are developed using the methods and processes in developing NICE guidelines: the manual and the interim principles for methods and processes for supporting digital living guideline recommendations.
If you have new information, intelligence or evidence relevant to any of the key topic areas listed above, please contact prioritisation@nice.org.uk.